jRCT2031230051已完成不适用
Phase 2 Allergen Challenge Trial of NTa53 in Patients with Allergic Conjunctivitis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Crossover Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 65age old not（—）
- 性别
- All
入选标准
- •Japanese adult between the age of 18 to under 65 years at the time of the informed consent
- •Specific IgE positive against cedar pollen allergens
- •Other protocol-specified inclusion criteria may apply
排除标准
- •Eye disease other than allergic conjunctivitis is present and requires treatment.
- •Other protocol-specified exclusion criteria may apply
结局指标
主要结局
-
Efficacy (Subjective Ocular Symptom Score and Objective Findings Score), Safety
次要结局
未报告次要终点
研究者
相似试验
招募中
2 期
Phase II-multicenter clinical trial of hypoallergenic wheat 1BS-18 HokushiWheat allergyJPRN-UMIN000024951Shimane University20
进行中（未招募）
1 期
A Phase II, pilot clinical trial to evaluate the effects of atorvastatin on Graves' Orbitopathy (GO) in hypercholesterolemic patients with moderate-to-severe and active GO subjected to intravenous glucocorticoid therapy.Graves’ orbitopathy is a disabling and disfiguring disease affecting the eyes observed in approximately 25-30% of patients with Graves’ disease. Its clinical manifestations include exophthalmos, inflammatory signs and symptoms, diplopia, and in most severe cases sight impairment.MedDRA version: 20.0Level: PTClassification code 10004161Term: Basedow's diseaseSystem Organ Class: 10014698 - Endocrine disordersEUCTR2018-001317-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA88
进行中（未招募）
1 期
Investigation of immunotherapy with nivolumab compared to nivolumab plus ipilimumab compared to placebo for patients with Stage IV melanoma with no evidence of disease after surgery or radiotherapyStage IV melanoma with no evidence of disease after surgery or radiotherapyMedDRA version: 20.0Level: PTClassification code 10025650Term: Malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001167-12-ATniversity of Essen312
进行中（未招募）
1 期
Investigation of immunotherapy with nivolumab or nivolumab / ipilimumab compared to placebo, respectively, for patients with stage IV melanoma with no evidence of disease after surgery or radiotherapyStage IV melanoma with no evidence of disease after surgery or radiotherapyMedDRA version: 21.1Level: PTClassification code 10025650Term: Malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001167-12-DEniversity of Essen167
进行中（未招募）
不适用
Phase 2 clinical trial of a gene therapy for choroideremiaEUCTR2015-001383-18-GBniversity of Oxford30